NCI
NASD Neo-Concept International Group Holdings Limited Class A$0.6952 ↑ +0.0001 (+0.01%) Trading Up from the previous close of $0.6951
- YTD change
- -92.31%
- vs 20-day SMA
- -69.77%
- vs 200-day SMA
- -95.72%
Price ranges
Price & Performance
-0.17 (-20.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.8% away from all-time highs of $455.6000
- NCI is down 92% since the beginning of the year
- NCI is down 95% over the past 12 months
- NCI is down 95% over the past 1 month
- 13% of all NCI investors are betting against NCI
NCI reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -58.9%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0003
- Last 5 days
- +0.80%
- vs 8-day SMA
- +2.27%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Neo-Concept International Group Holdings Ltd. engages in providing one-stop apparel solution services. Its services include product design and development, raw material sourcing, production and quality control, and logistics management. It operates through the following geographical segments: The United States and Canada, The United Kingdom, and Others. The company was founded in October 1990 and is headquartered in Hong Kong.
Competitor comparison
| Ticker | Company | Price | Change |
|---|---|---|---|
| HESAY | Hermes International Societe en commandite par actions Unsponsored ADR | $152.84 | +1.64% |
| ATZAF | Aritzia, Inc. | $109.50 | +0.58% |
| ONON | On Holding AG Class A | $34.22 | -3.39% |
| BSDGY | Bosideng International Holdings Limited Unsponsored ADR | $27.75 | -6.62% |
| FIGS | FIGS, Inc. Class A | $19.98 | +0.60% |
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
